Pharmacology, Toxicology and Pharmaceutical Science
Migraine
88%
Headache
30%
Placebo
23%
Episodic Migraine
17%
Calcitonin Gene Related Peptide
15%
Transformed Migraine
13%
Cluster Headache
10%
Erenumab
10%
Tolerability
9%
Clinical Trial
9%
Adverse Event
7%
Monoclonal Antibody
7%
Calcitonin Gene Related Peptide Receptor Antagonist
6%
Ubrogepant
6%
Migraine with Aura
6%
Rimegepant
5%
Galcanezumab
5%
Receptor
5%
Pathophysiology
5%
Neuroscience
Migraine
100%
Headache
47%
Auras
17%
Cluster Headache
15%
Receptor
12%
Placebo
7%
Calcitonin
7%
Spreading Cortical Depression
6%
Nitroglycerin
6%
Triptan
5%
Medicine and Dentistry
Migraine
65%
Headache
38%
Transformed Migraine
12%
Cluster Headache
10%
Episodic Migraine
9%
Primary Headache
9%
Placebo
8%
Pathophysiology
7%
Diseases
7%
Migraine with Aura
6%
Auras
6%
Chronic Cluster Headache
5%